Last $32.95 USD
Change Today -0.06 / -0.18%
Volume 545.5K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 12:48 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jerry S. Lanchbury Ph.D.

Chief Scientific Officer, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$1,883,706
As of Fiscal Year 2012

Background*

Dr. Jerry S. Lanchbury, Ph.D. serves as Chief Scientific Officer of Myriad Genetics Inc. Dr. Lanchbury served as Executive Vice President of Research at Myriad Genetics Inc. Dr. Lanchbury joined Myriad Genetics in September 2002. He served as Senior Vice President of Research and Development of Myriad Genetics Inc., since January 22, 2003. He developed DNA-based analysis techniques for investigating the genetic basis of complex diseases with a focus on rheumatoid arthritis ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Aston University

Other Affiliations*

Annual Compensation*

Salary$420,812
Bonus$244,761
Total Annual Compensation$665,573

Stock Options*

All Other Compensation$10,411
Exercised Options51,804
Exercised Options Value$815,073
Exercisable Options436,978
Exercisable Options Value$3,184,890
Unexercisable Options354,000
Unexercisable Options Value$1,306,610
Total Value of Options$5,306,573
Total Number of Options842,782

Total Compensation*

Total Annual Cash Compensation$675,984
Total Short Term Compensation$665,573
Other Long Term Compensation$10,411
Total Calculated Compensation$1,883,706
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $32.95 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
$1.4M
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Susan Searle Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
245.0K GBP
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.